Literature DB >> 12775260

[Diagnosis of pulmonary sclerosing hemangioma with incremental dynamic CT: analysis of 20 cases].

Ru-ming Xie1, Xin-hua Zhou, Ping-xin Lü, Wei He.   

Abstract

OBJECTIVE: To evaluate the value of incremental dynamic CT in the diagnosis of pulmonary sclerosing hemangioma (sclerotic hemangioma).
METHODS: Thin-section CT at 2.0 mm thickness and 2.0 mm interval was performed before and after administration of contrast material in 20 cases of pulmonary sclerosing hemangioma.
RESULTS: Pulmonary sclerosing hemangiomas were shown to be round or oval masses, with smooth margins, homogeneous parenchymal density, and occasional calcification. Homogeneous enhancement was evident in all cases, with maximum CT values ranging from 90 to 110 HU.
CONCLUSION: Spiral dynamic CT is useful in the diagnosing of sclerosing hemangioma in the lungs.

Entities:  

Mesh:

Year:  2003        PMID: 12775260

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  4 in total

1.  Preoperative Diagnosis in 46 Cases of Pulmonary Sclerosing Hemangioma.

Authors:  Ai-Min Hu; Dan Zhao; Hua Zheng; Qun-Hui Wang; Yan Lyu; Bao-Lan Li
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

2.  Pulmonary sclerosing pneumocytoma of the lung: CT characteristics in a large series of a tertiary referral center.

Authors:  So Youn Shin; Mi Young Kim; Sang Young Oh; Hyun Joo Lee; Soon Auck Hong; Se Jin Jang; Sung-Soo Kim
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

3.  18 F-FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma.

Authors:  Jie Xu; Youwen Dong; Guotao Yin; Wei Jiang; Zhen Yang; Wengui Xu; Lei Zhu
Journal:  Thorac Cancer       Date:  2019-05-27       Impact factor: 3.500

Review 4.  Pulmonary sclerosing pneumocytoma in an 18-year-old male patient: A case report and literature review.

Authors:  Huu Y Le; Dinh Phuc Pham; Khac Tuyen Nguyen; Van Ai Hoang; The Son Trinh; Quyet Do
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.